Cholesteatoma symptoms often look like nothing more than recurring earwax and a bit of discharge. Behind that quiet presentation is skin growing where skin does not belong — and slowly dissolving bone. Here is how it starts, how it is diagnosed, and why surgery is the only treatment that ends it.
Most laryngomalacia in infants resolves without treatment by the first birthday, but a small group needs more than reassurance. Here is how to tell the difference, what the diagnosis involves, and why recent evidence has changed the role of reflux medication.
The Fine Needle Aspiration vs Core Needle Biopsy decision is not about needle size. One samples cells, the other samples tissue with its architecture intact — and they fail in different ways. What the published data say about accuracy, sampling error, and complication rates in the head and neck.
More than a third of ears tested in hyperacusis patients show entirely normal thresholds. A look at hyperacusis symptoms and causes — and why no single test confirms the diagnosis.
Fungal sinusitis is not one disease but five — from a harmless fungal ball cured by a single operation to an invasive form that kills roughly half of those who develop it. Here is how to tell them apart, and which one needs surgery, medication, or both.
Small-cap biotech investing fails most people for structural reasons, not for lack of discipline. Value arrives in blocks on scheduled dates, funding arrives through dilution, and the probabilities underneath every valuation model are contested by a factor of two.
The sinus microbiome is reshaping how we understand chronic sinusitis — from a single infection to a disturbed ecosystem. Here’s what the evidence supports, and what remains unproven.
An otolaryngologist’s guide to nose-to-brain drug delivery — how nasal sprays reach the brain, which treatments are already approved, and why an open nasal airway decides whether they work.
The FDA’s approval of tirzepatide for sleep apnea gave OSA its first-ever drug. Here’s what it treats, how it works, and the oral pill coming next.
What is the depression nasal spray? A concise, evidence-based look at esketamine (Spravato) — its mechanism, FDA-approved uses, trial results, and commercial rise.
